Exosomes are cell-derived vesicles containing heterogeneous active biomolecules such as
proteins, lipids, mRNAs, receptors, immune regulatory molecules, and nucleic acids. They
typically range in size from 30 to 150 nm in diameter. An exosome’s surfaces can
be bioengineered with antibodies, fluorescent dye, peptides, and tailored for small
molecule and large active biologics. Exosomes have enormous potential as a drug delivery
vehicle due to enhanced biocompatibility, excellent payload capability, and reduced
immunogenicity compared to alternative polymeric-based carriers. Because of active
targeting and specificity, exosomes are capable of delivering their cargo to
exosome-recipient cells. Additionally, exosomes can potentially act as early stage
disease diagnostic tools as the exosome carries various protein biomarkers associated
with a specific disease. In this review, we summarize recent progress on exosome
composition, biological characterization, and isolation techniques. Finally, we outline
the exosome’s clinical applications and preclinical advancement to provide an
outlook on the importance of exosomes for use in targeted drug delivery, biomarker
study, and vaccine development.
Opportunistic fungal infections are responsible for over 1.5 million deaths per year. This has created a need for highly effective antifungal medication to be as potent as possible. In this study, we improved the efficacy of a common over the counter (OTC) antifungal skin medication, miconazole, by encapsulating nano-molecules of the drug in cholesterol/sodium oleate nano-vesicles. These nano-vesicles were characterized to optimize their size, zeta potential, polydispersity index and encapsulation efficiency. Furthermore, these nano-vesicles were compared to a conventional miconazole-based commercially available cream to determine potential improvements via permeation through the stratum corneum, cytotoxicity, and antifungal capabilities. Our results found that the vesicle size was within the nano range (~300 nm), with moderate polydispersity and stability. When compared with the commercially available cream, Actavis, as well as free miconazole, the miconazole nano-vesicle formulation displayed enhanced fungal inhibition by a factor of three or more when compared to free miconazole. Furthermore, with smaller nanoparticle (NP) sizes, higher percentages of miconazole may be delivered, further enhancing the efficacy of miconazole’s antifungal capability. Cytotoxicity studies conducted with human dermal fibroblast cells confirm its biosafety and biocompatibility, as cell survival rate was observed to be twofold higher in nano-vesicle formulation than free miconazole. This formulation has the potential to treat fungal infections through increasing the retention time in the skin, improving the treatment approach, and by enhancing the efficacy via the use of nano-vesicles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.